Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.

The aim of the study was to determine the maximum tolerated dose (MTD) for the combination of high-dose epirubicin and vinorelbine in chemotherapy-naive patients with inoperable non-small-cell lung cancer (NSCLC). Twenty-one patients with stage IIIB and IV NSCLC were treated in a single-centre study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakker, M., Groen, H. J., Smit, E. F., Smeets, J., Riggi, M., Postmus, P. E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034068/
https://www.ncbi.nlm.nih.gov/pubmed/8519675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034068/
https://www.ncbi.nlm.nih.gov/pubmed/8519675

Ejemplares similares